Covalon Technologies Ltd.
405 Britannia Road East
Suite 106
Mississauga
Ontario
L4Z 3E6
Canada
Tel: 905-568-8400
Fax: 905-568-5200
Website: http://www.covalon.com/
Email: office@covalon.com
187 articles about Covalon Technologies Ltd.
-
Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders
3/7/2024
Covalon Technologies Ltd., an advanced medical technologies company, announced the results of the matters voted upon at its Fiscal 2023 Annual Meeting of Shareholders held March 6, 2024.
-
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024
2/28/2024
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 6, 2024 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast.
-
Covalon Announces First Quarter Fiscal 2024 Results
2/28/2024
Covalon Technologies Ltd. today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.
-
Covalon Announces Management Changes
1/26/2024
Covalon Technologies Ltd. today announced the following management changes.
-
Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023
1/26/2024
Covalon Technologies Ltd. today announced its fiscal 2023 fourth quarter and year end results for the period ended September 30, 2023.
-
Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO
1/4/2024
Covalon Technologies Ltd. today announced that its Board of Directors (the “ Board ”) has appointed Mr. Brent Ashton to serve as Chief Executive Officer and a director of the Company, effective immediately.
-
Covalon Announces Issuance of Deferred Share Units - October 20, 2023
10/20/2023
Covalon Technologies Ltd., an advanced medical technologies company, is pleased to announce that the Company's Board of Directors has approved the grant of an aggregate of 295,000 deferred stock units to certain of its directors and officers.
-
Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR
10/13/2023
Covalon Technologies Ltd., a leader in advanced medical technologies, announced its participation in the Association for Vascular Access Annual Scientific Meeting Conference and Exhibit, to be held in Portland, Oregon from Saturday, October 14 to Monday, October 16, 2023.
-
Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago
10/11/2023
Covalon Technologies Ltd., a leader in advanced medical technologies, announced its participation in the American Nurses Credentialing Center Magnet Conference.
-
Covalon Announces Leadership Changes
9/26/2023
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that its Board of Directors (the “Board”) has appointed Amir Boloor, Chair of the Company’s Board, as Interim Chief Executive Officer (“CEO”), effective immediately following the departure of Brian Pedlar.
-
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference
9/19/2023
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference.
-
Covalon Announces Third Quarter Fiscal 2023 Results
8/16/2023
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its third quarter fiscal 2023 results.
-
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2023 Financial Results
8/14/2023
Covalon Technologies Ltd. will release its Q3 Fiscal 2023 financial results on Wednesday, August 16, 2023, before markets open.
-
Premier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites
7/18/2023
Covalon Technologies Ltd. announced the publication of an article in the Journal of the Association for Vascular Access, titled “Guarding the Central Venous Access Device: A New Solution for an Old Problem”, authored by Darcy Doellman, MSN, RN, VA-BC, a leading expert in pediatric vascular access.
-
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023
6/27/2023
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023.
-
Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida
6/26/2023
Visit booth 612 to discover how Covalon is setting new standards in compassionate innovation for infection prevention solutions that deliver tough protection with gentle care.
-
Webinar on Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention, Presented by Covalon
6/21/2023
Covalon Technologies Ltd. today announced an expert-led webinar titled “Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention” will be held on Thursday, June 22, 2023 at 1pm ET.
-
Breakthrough Solution for Fragile Skin: Covalon’s IV Clear® Dressing Recommended by Physicians at a Top 10 U.S. Children’s Hospital and Epidermolysis Bullosa Center of Excellence
6/13/2023
Covalon Technologies Ltd., an advanced medical technologies company, announced that its IV Clear® line of dual antimicrobial silicone dressings has been recommended by physicians at a Top 10 U.S.
-
Covalon Announces Second Quarter Results for Fiscal 2023
5/25/2023
Covalon Technologies Ltd., an advanced medical technologies company, announced its second quarter fiscal 2023 results.
-
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2023 Financial Results
5/23/2023
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2023 financial results on Thursday, May 25, 2023, before markets open.